Beijing Leadman Biochemistry Co Ltd Total Assets

Latest as of March 2026: CN¥1.76 Billion CNY ≈ $258.19 Million USD

Beijing Leadman Biochemistry Co Ltd total assets. Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) holds total assets worth CN¥1.76 Billion CNY (≈ $258.19 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Beijing Leadman Biochemistry Co Ltd (300289) market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Beijing Leadman Biochemistry Co Ltd (2008–2025)

Total assets of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025. This chart illustrates how Beijing Leadman Biochemistry Co Ltd's total assets have evolved over time, based on quarterly financial data. See latest Beijing Leadman Biochemistry Co Ltd stock price today for real-time trading data and today's change.

Beijing Leadman Biochemistry Co Ltd - Asset Composition Analysis

Beijing Leadman Biochemistry Co Ltd Total Assets Breakdown (December 2025)

Beijing Leadman Biochemistry Co Ltd total assets breakdown as of December 2025. Beijing Leadman Biochemistry Co Ltd's total assets of CN¥1.76 Billion consist of 62.1% current assets and 38.0% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 31.9%
Accounts Receivable CN¥85.87 Million 4.8%
Inventory CN¥88.72 Million 5.0%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥20.98 Million 1.2%
Goodwill CN¥73.53 Million 4.1%

Asset Composition Trend (2008–2025)

This chart illustrates how Beijing Leadman Biochemistry Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Beijing Leadman Biochemistry Co Ltd to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Beijing Leadman Biochemistry Co Ltd's current assets represent 62.1% of total assets in 2025, a decrease from 64.2% in 2008.
  • Cash Position: Cash and equivalents constituted 31.9% of total assets in 2025, up from 24.8% in 2008.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 4.0% in 2008.
  • Asset Diversification: The largest asset category is inventory at 5.0% of total assets.

Beijing Leadman Biochemistry Co Ltd Competitors by Total Assets

Key competitors of Beijing Leadman Biochemistry Co Ltd based on total assets are shown below.

Company Country Total Assets
HOB Biotech Group Corp Ltd
SHG:688656
China CN¥916.43 Million
L&C Bio Co. Ltd
KQ:290650
Korea ₩497.94 Billion
Applied BioCode
TW:6598
Taiwan NT$1.03 Billion
Oncosil Medical Ltd
AU:OSL
Australia AU$7.13 Million
Sequana Medical NV
BR:SEQUA
Belgium €14.57 Million
Cleo Diagnostics Ltd
AU:COV
Australia AU$9.96 Million
Radiant Innovation
TWO:3373
Taiwan NT$859.52 Million
MedX Health Corp
V:MDX
Canada CA$1.26 Million

Beijing Leadman Biochemistry Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 13.99 15.64 6.32
Quick Ratio 12.88 14.39 5.48
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥1.03 Billion CN¥1.04 Billion CN¥554.43 Million

Beijing Leadman Biochemistry Co Ltd - Advanced Valuation Insights

This section examines the relationship between Beijing Leadman Biochemistry Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.99
Latest Market Cap to Assets Ratio 0.27
Asset Growth Rate (YoY) -2.5%
Total Assets CN¥1.78 Billion
Market Capitalization $475.25 Million USD

Valuation Analysis

Below Book Valuation: The market values Beijing Leadman Biochemistry Co Ltd's assets below their book value (0.27x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Beijing Leadman Biochemistry Co Ltd's assets decreased by 2.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Beijing Leadman Biochemistry Co Ltd (2008–2025)

The table below shows the annual total assets of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025.

Year Total Assets Change
2025-12-31 CN¥1.78 Billion
≈ $259.91 Million
-2.54%
2024-12-31 CN¥1.82 Billion
≈ $266.68 Million
-5.98%
2023-12-31 CN¥1.94 Billion
≈ $283.65 Million
-2.94%
2022-12-31 CN¥2.00 Billion
≈ $292.24 Million
-14.96%
2021-12-31 CN¥2.35 Billion
≈ $343.65 Million
+44.20%
2020-12-31 CN¥1.63 Billion
≈ $238.32 Million
-4.99%
2019-12-31 CN¥1.71 Billion
≈ $250.84 Million
-0.87%
2018-12-31 CN¥1.73 Billion
≈ $253.04 Million
-1.41%
2017-12-31 CN¥1.75 Billion
≈ $256.65 Million
+5.48%
2016-12-31 CN¥1.66 Billion
≈ $243.33 Million
+0.25%
2015-12-31 CN¥1.66 Billion
≈ $242.72 Million
+2.63%
2014-12-31 CN¥1.62 Billion
≈ $236.50 Million
+29.92%
2013-12-31 CN¥1.24 Billion
≈ $182.03 Million
+10.07%
2012-12-31 CN¥1.13 Billion
≈ $165.38 Million
+209.09%
2011-12-31 CN¥365.66 Million
≈ $53.51 Million
+41.34%
2010-12-31 CN¥258.71 Million
≈ $37.86 Million
+69.09%
2009-12-31 CN¥153.00 Million
≈ $22.39 Million
+34.32%
2008-12-31 CN¥113.91 Million
≈ $16.67 Million
--

About Beijing Leadman Biochemistry Co Ltd

SHE:300289 China Medical Devices
Market Cap
$475.25 Million
CN¥3.25 Billion CNY
Market Cap Rank
#12214 Global
#3501 in China
Share Price
CN¥5.97
Change (1 day)
+1.36%
52-Week Range
CN¥5.28 - CN¥9.25
All Time High
CN¥23.05
About

Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more